Cradle

About

Cradle, a pioneering platform in the field of protein engineering, utilizes advanced machine learning to transform the way proteins are designed. This innovative tool aims to streamline and accelerate the protein design process significantly, enabling researchers and scientists to develop proteins with specific properties more efficiently than traditional methods allow. By employing cutting-edge generative machine learning models, Cradle predicts optimal genetic modifications required for desired protein characteristics, thus bypassing the trial-and-error limitations of conventional approaches. At the core of Cradle’s capabilities are its generative machine learning models, which are honed on an extensive dataset comprising nearly one billion protein sequences. These models enable the platform to predict the performance of various protein variants accurately. As each experimental cycle is completed, the models learn and enhance their predictive accuracy and protein design capabilities, providing users with optimized protein variants more swiftly. Cradle is designed for a diverse range of applications across several industries. In therapeutics, it aids in designing more effective enzymes, antibodies, and vaccines. In the chemical sector, it facilitates the creation of novel enzymes suitable for sustainable chemical synthesis and biomanufacturing. Further applications include developing new proteins for bio-based materials and plastics, as well as engineering proteins to enhance food production and processing. Among Cradle’s unique selling points are its ability to optimize multiple protein properties in a single design cycle, its user-friendly interface that simplifies use for individuals without a machine learning background, and its strong emphasis on data privacy and security. These elements ensure that user data remains confidential while granting users ownership over their intellectual outputs. The platform is also integrated with Ginkgo Bioworks' Foundry, ensuring seamless communication and data exchange between systems—an accolade to its integration capabilities. Notably, Cradle has secured a seed funding round of €5.5 million, underscoring confidence from prominent investors like Index Ventures and Kindred Capital. Recognized for its leadership in AI-driven biology and protein engineering, it continuously receives attention for its contributions to the field. Recent developments include a strategic partnership with Ginkgo Bioworks, aimed at expanding the reach of its machine learning technology to additional bio research and development teams. Cradle actively engages its community through informative blog posts, offering insights into AI in protein design and best practices for data collection. Through these advancements and features, Cradle stands out as a transformative tool in bioengineering, offering a sophisticated, efficient, and secure solution for modern protein design challenges.

Details

Video